Psychedelic 'breakthrough' therapies approved in Australia for PTSD, depression

Psychedelic drugs showing promising results in clinical trials for mental health conditions
Australia has become one of the first countries to allow the medical use of MDMA and magic mushrooms for certain mental health conditions.
The reclassification of these drugs in Australia was based on trials that found them to be relatively safe in a medically-controlled environment.
Australia is the first country to allow psychiatrists to prescribe psychedelic substances to patients with depression or post-traumatic stress disorder.
The use of psychedelics in treatment is not endorsed by the American Psychiatric Association, and more research is needed on their efficacy and risks.